Evidence map›Paper›PMID 36660470›Full record

ReviewGastroenterology research2022

An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma.

Robert J Wong, Channa Jayasekera, Patricia Jones, Fasiha Kanwal, Amit G Singal, Aijaz Ahmed, Robert Taglienti, Zobair Younossi, Laura Kulik, Neil Mehta

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Gastroenterology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 2 countries.

Robert J WongVeterans Affairs Palo Alto Healthcare System, Stanford University School of Medicine, Palo Alto, CA, USA.
Channa JayasekeraMayo Clinic, Phoenix, AZ, USA.
Patricia JonesUniversity of Miami, Miami, FL, USA.
Fasiha KanwalMichael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX, USA.
Amit G SingalUniversity of Texas Southwestern Medical Center, Dallas, TX, USA.
Aijaz AhmedStanford University School of Medicine, Stanford, CA, USA.
Robert TaglientiChronic Liver Disease Foundation, Clark, NJ, USA.
Zobair YounossiInova Fairfax Hospital, Falls Church, VA, USA.
Laura KulikNorthwestern University, Chicago, IL, USA.
Neil MehtaUniversity of California, San Francisco, CA, USA.
Stanford University · USChronic Liver Disease Foundation · USInova Fairfax Hospital · USMayo Clinic Hospital · USMichael E. DeBakey VA Medical Center · USNorthwestern University · USThe University of Texas Southwestern Medical Center · USUniversity of California, San Francisco · USUniversity of Miami · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is increasing in incidence and is a leading cause of cancer-related mortality worldwide. Adherence to HCC surveillance guidelines and appropriate treatment triage of liver lesions may improve receipt of curative-intent treatment and improved survival. Late-stage HCC diagnosis reflects sub-optimal implementation of effective HCC surveillance, whereas inappropriate treatment triage or linkage to care accounts for the non-receipt of curative-intent in close to half of early-stage HCC in the USA. A free, open-access decision-support tool for liver lesions that incorporates current guideline recommendations in a user-friendly interface could improve appropriate and timely triage of patients to appropriate care. This review provides a summary of gaps and disparities in linkage to HCC care and introduces a free, internet-based, interactive decision-support tool for managing liver lesions. This tool has been developed by the HCC Steering Committee of the Chronic Liver Disease Foundation and is targeted toward clinicians across specialties who may encounter liver lesions during routine care or as part of dedicated HCC surveillance.

Indexed as

Barcelona Clinic Liver Cancer staging systemCascade of careDigital decision-support toolHepatocellular carcinomaSurveillance

Identifiers

PMID36660470
PMCPMC9822660
OpenAlexW4311978577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.